期刊文献+

加拿大预防药品短缺策略简介及对我国的启示 被引量:6

The strategies of preventing drug shortage in Canada and its implications to China
下载PDF
导出
摘要 目的为我国制订预防药品短缺相关措施提供参考。方法运用文献资料法,对加拿大预防药品短缺策略进行介绍与分析。结果加拿大制订的预防药品短缺策略通过确定基本药物、完善药品定价政策、加强药企监管、建立信息平台、明确利益相关者职责、重视与国际组织的合作来保障药品供应。结论加拿大预防药品短缺策略可为我国制订相关措施提供参考。 Objective To provide suggestions to improve our drug shortage strategies. Methods The study was done by literature research methods from introducing and analyzing the strategies of preventing drug shortage in Canada. Re- sults Canada took some steps to prevent drug shortage including determining essential drugs, improving drug pricing policy, strengthening the supervision of the pharmaceutical companies, establishing information platforms, determining stakeholder responsibilities and emphasizing cooperation with international organizations. Conclusion The strategies in Canada are of significant importance to the improvement of our drug shortage strategies.
出处 《中国医药导报》 CAS 2013年第6期155-157,共3页 China Medical Herald
关键词 药品短缺 供应 策略 基本药物 Drug shortage Supply Strategy Essential drug
  • 相关文献

参考文献1

二级参考文献41

  • 1FDA. Manual of Policies and Procedures (MAPP) 6003.1 [ EB/ OL]. ( 2012 - 02 - 03 ). http.//www, fda. gov/downloads/ AboutFDA/CentersOffices/C DE R/ManualofPoliciesProcedures/ ucm079936, pdf. 被引量:1
  • 2LYNN S. U.S. drug shortages [EB/OL]. [2012-10-10]. http.//www, ovariancancer, org/wp-content/uploads/2012/08/ dsLynn, pdf. 被引量:1
  • 3FDA. A review of FDA's approach to medical product shortage [ EB/OL]. [ 2012 - 10 - 10 ]. http.//www, fda. gov/down- loads/aboutfda/reportsmanualsforms/reports/ucm277755, pdf. 被引量:1
  • 4CHABNER BA. Drug shortages-a critical challenge for the gener- ic-drugmarket [J]. NEngl JMed, 2011, 365(23), 2147 - 2149. 被引量:1
  • 521 USC § 356c-Discontinuance of life saving product [ EB/OL]. (2012 -01 ). http.//www, law. comell, edu/uscode/text/21/ 356c. 21 USC § 356c-Discontinuance of life saving product. 被引量:1
  • 6VENTOLA CL. The drug shortage crisis in the United States, causes, impact, and management strategies [ J]. Pharm Ther, 2011, 36(11). 740-742,749-757. 被引量:1
  • 7LE P, ENRIQUE SV, ROSA RM, et al. The prevalence of phar- maceutical shortages in the United States[ J]. J Gene Med. The Business Journal of the Generic Medicines Sector, 2011, 8 ( 4 ) . 210 -218. 被引量:1
  • 8HILL JM, REILLY C. "Can the United States ensure an ade- quate supply of critical medications," ( FDLI's Food and Drug Policy Forum, 2011 ) [ EB/OL]. [2012 - 10 - 10 ]. http./! www. ashp. org/DocLibrary/Policy/DrugShortages/FDLI-Article- on-Drug-Shortages, aspx. 被引量:1
  • 9FDA. Guidance for industry notification to FDA of issues that may result in a prescription drug or biological product shortage DRAFT GUIDANCE [ EB/OL ]. [ 2011 - 12 ]. http .//www. fda. gov/downloads/Drugs/GuidanceComplianceRegulatorylnformation/ Guidances/UCM292426 pdf. 被引量:1
  • 10HDMA White Paper on Product Availability-Communication guidelines for managing product shortages in the healthcare supply Chain [ EB/OL]. (2012 - 04 - 18). http.//www, heahhcare- distribution, org/ir_issues/pdfs/2012 -04 - 18-ProductAvailabil- ityGuidelines, pdf. 被引量:1

共引文献11

同被引文献55

引证文献6

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部